MNPR vs REGN: Which Stock is Better?
Side-by-side comparison of Monopar Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
MNPR
Monopar Therapeutics Inc
—
REGN
Regeneron Pharmaceuticals Inc
$649.81
Key Metrics Comparison
| Metric | MNPR | REGN | Winner |
|---|---|---|---|
| Market Cap | $431.35M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze MNPR
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MNPR or REGN a better investment?
Comparing MNPR and REGN: Monopar Therapeutics Inc has a market cap of $431.35M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MNPR and REGN?
MNPR (Monopar Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MNPR or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MNPR or REGN?
Both MNPR and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: MNPR or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: MNPR or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $431.35M for MNPR.
Should I buy MNPR or REGN in 2026?
Both MNPR and REGN have investment merit. MNPR trades at $N/A while REGN trades at $649.81. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MNPR and REGN stock?
Key differences: Market Cap ($431.35M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy MNPR or REGN in 2026?
The choice between MNPR and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between MNPR and REGN?
MNPR (Monopar Therapeutics Inc) has a market cap of $431.35M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.